Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$579,080
+$1,380 QoQ
Shares Held
3,695
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#828
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PATTON ALBERTSON MILLER GROUP, LLC holds $20,615,564 across 9 Drug Manufacturers - General names. NVS ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,338 | $6,181,121 | |
| 2 | MRK |
Merck & Co., Inc.
|
39,923 | $5,130,105 | |
| 3 | ABBV |
AbbVie Inc.
|
19,350 | $4,869,234 | |
| 4 | AMGN |
Amgen Inc
|
5,206 | $1,885,196 | |
| 5 | LLY |
ELI LILLY & Co
|
876 | $1,050,700 | |
| 6 | NVS |
Novartis AG
This page
|
3,695 | $579,080 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,144 | $397,212 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,289 | $304,752 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,080 | 3,695 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $577,700 | 3,782 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $554,651 | 4,023 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $546,174 | 4,259 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $580,605 | 4,798 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $553,386 | 4,964 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $528,295 | 5,429 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $627,894 | 5,459 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $581,910 | 5,466 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $549,523 | 5,681 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $581,991 | 5,764 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $597,307 | 5,864 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $596,781 | 5,914 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $588,248 | 6,394 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $583,692 | 6,434 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $525,913 | 6,919 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $638,032 | 7,548 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $864,600 | 9,853 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $860,704 | 9,840 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,019,387 | 12,465 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,162,397 | 12,740 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,179,794 | 13,802 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $1,300,962 | 13,777 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $1,301,704 | 14,969 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,426,000 | 16,327 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,346,161 | 16,327 | Shares | Sole | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||